Total Funding
44
16
Total FundingGrant raised
Growth Score 44 in past quarter
-4 pts
Heat Score 16 in past quarter
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
1001173
Blaze Medical Devices was initially formed as a Michigan LLC in 2006. For the first few years, its founders focused on developing its core
Michael Tarasev: Founder, COO and CSOPast Role: University of Michigan, Reseach Associate
Kenneth Alfano: Founder and CTO
About the Company
Blaze develops technologies that enable integrated and standardized assessments of blood damage, particularly for red blood cells (RBC). The company’s principal product lines include RBC Mechanical Fragilimeter™ systems for testing the mechanical fragility (MF) of red blood cells, and RBC Hemolysis Tester systems which also include the
Fragilimeter™ capability. Initial models of these systems are for a wide range of industrial R&D and other research applications, while subsequent lines will target medical applications.

